Serrano-Combarro et al. Abatacept in RA-ILD. 343 patients. In 23.3% ILD progressed on abatacept. Is that good or bad? We need comparative studies! @RheumNow #ACR24 Abstr#0475 https://t.co/nUEDdjGguA https://t.co/sXEF72MafK
Links:
Rheumatoid Arthritis - Progressive Interstitial Lung Disease with Abatacept: Da…
https://acrabstracts.org/abstract/rheumatoid-arthritis-progressive-interstitial…
16-11-2024